Abstract
Several vaccine technologies were evaluated for their abilities to induce anti-human immunodeficiency virus Gag immune responses in rhesus macaques. While no vaccine alone was able to induce broad and strong immune responses, these were achieved by priming with Gag DNA and boosting with Gag protein adsorbed to polylactide coglycolide microparticles. This regimen elicited strong antibodies, helper T cells, and cytotoxic T lymphocytes and thus holds promise as an effective vaccination scheme.
MeSH terms
-
AIDS Vaccines / administration & dosage
-
AIDS Vaccines / immunology*
-
Animals
-
Gene Products, gag / chemistry
-
Gene Products, gag / genetics
-
Gene Products, gag / immunology*
-
HIV Antibodies / blood
-
HIV Infections / immunology
-
HIV Infections / prevention & control
-
Humans
-
Immunization
-
Immunization, Secondary*
-
Lactic Acid / immunology*
-
Lymphocyte Activation
-
Macaca mulatta
-
Microspheres*
-
Polyglycolic Acid
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Polymers
-
T-Lymphocytes / immunology
-
Vaccines, DNA / administration & dosage
-
Vaccines, DNA / immunology*
Substances
-
AIDS Vaccines
-
Gene Products, gag
-
HIV Antibodies
-
Polymers
-
Vaccines, DNA
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Polyglycolic Acid
-
Lactic Acid